Dr Redwood will study different types of mutation in the beta-tropomyosin gene in order to find out how it affects the function and stability of the contractile machinery of the muscle. He will be able to compare both normal and mutated proteins in order to determine how their properties differ.
Understanding how faults in the contractile machinery can cause muscle disease is an important step forward as it will yield not only new information on the congenital myopathies but also may highlight some potential therapeutic targets for future studies.
Project leader: Dr Charles Redwood
Location: University of Oxford
Duration of project: 3 years (starting December 2008)
Total project cost: £150,100
Official project title: Analysis of the effects on contractile function of mutations in beta-tropomyosin that cause different inherited myopathies
It is only through your contributions that we can continue to fund the vital work that takes us closer to finding treatments and cures for muscle disease. Donate now and help change the lives of thousands of people living with muscle disease. Thank you for your support.